Protease-activated receptor 3 is a second thrombin receptor in humans
about
Rab6 is phosphorylated in thrombin-activated platelets by a protein kinase C-dependent mechanism: effects on GTP/GDP binding and cellular distributionThrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathwayCellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substratesProteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytesArginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretionThrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1Cloning and characterization of human protease-activated receptor 4Thrombin receptor overexpression in malignant and physiological invasion processesProtease-activated receptors 1 and 4 mediate activation of human platelets by thrombinProtease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activityStrain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient miceSignalling pathways induced by protease-activated receptors and integrins in T cellsMolecular cloning of the rat proteinase-activated receptor 4 (PAR4)G Protein-Coupled Receptors in CancerNew insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptorsThe Importance of Thrombin in Cerebral Injury and DiseaseMechanisms regulating endothelial permeabilityEnteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsMechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombinCrystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4Crystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1Gene and locus structure and chromosomal localization of the protease-activated receptor gene familyDesign, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptorEvidence that PAR-1 and PAR-2 mediate prostanoid-dependent contraction in isolated guinea-pig gallbladderIn vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouseMechanism of trypsin-induced contraction in the rat myometrium: the possible involvement of a novel member of protease-activated receptorContractile actions of proteinase-activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systemsInitiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cellsGlycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptaseMechanism of trypsin-induced endothelium-dependent vasorelaxation in the porcine coronary arteryDual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1Protease-activated receptor-4: a novel mechanism of inflammatory pain modulationChanges in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesionPAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiologyEvolution of the protease-activated receptor family in vertebratesProteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connectionSensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory painEnhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.Induction of release and up-regulated gene expression of interleukin (IL)-8 in A549 cells by serine proteinases.
P2860
Q22003809-103D4D1C-E9D0-4A8A-8330-A4F850C1EA3EQ22253244-BE01C92B-708E-4FBA-BD9B-1507A69D6A44Q22254229-63A986A0-1246-4F05-89FC-2F9D7B3E6F09Q24291341-64BA249D-1D86-4FD8-B8A4-71FE2A37EDC7Q24291430-7FA2A317-E027-4D03-A454-9C0B8F9D3E4BQ24309637-B8702B68-7E2C-4B97-8F0A-3CD5321E8F73Q24322941-C78618F6-3C54-4065-A011-EB8F06A94F27Q24323035-0765DD84-9DA2-46DE-A416-DFD5D34C3BE5Q24563384-E6F47A2E-C5C3-4702-92C1-E6D6C61BF7D5Q24673539-6B375450-0792-45F6-A399-1247E2FA8ED8Q24680458-91064E72-B901-4CC9-A08E-24815E164EDAQ24682815-8773BCEC-10D1-4965-AF1E-2419403B8F99Q24804149-D35E0564-E664-4B90-8906-9D5C56713E47Q26741203-7E55E312-977B-4317-9E63-D88C9D057D24Q26765204-08DBD967-9EE8-4E72-9DC2-3371784312C2Q26772131-478E961E-499D-434F-8333-5E419A42848AQ26866511-9BAD583E-1E7D-47CE-AE69-7BC9B7E0750BQ27027602-8009FB6F-9CF7-4D2A-9B64-59B54DF7700CQ27640570-C04699DF-0729-4AAB-81A3-8455E0E07DB9Q27646532-61E39F86-FB39-4DE7-BB62-47A93649AE46Q27660263-213C4CFB-3CF3-4F0B-8998-7751C8FED55FQ28281095-F088B539-2779-40D2-9B0E-43C8DE3B99EFQ28343653-EFAEA4BD-9AED-4668-9F95-CF3C66695EFBQ28344849-7981B541-0168-4B1F-921B-79513901AC0DQ28345742-7CE1B0A3-AAC6-4B0C-9059-89A4669A1A40Q28345766-53B3167C-2F5B-4788-B5EB-8D5229BDC707Q28346428-CC25F629-8EFD-4C00-B3D2-F1CF94C373E4Q28348328-533DFC57-AB97-4559-8FA6-0901432603D2Q28361185-7E0FE66D-A6FA-4FF9-AE93-7708A79F0215Q28362035-6AFBF4F2-1534-4D1C-96F0-93C32E360419Q28362075-959B9448-023E-4645-A749-C50FC3C52968Q28578188-245B24FD-0173-4B2C-BB73-553965CE60A1Q28580202-12E0D8B5-7DCC-491D-A19B-C4BAFE037A1BQ28582819-C0D4FE84-27E4-42ED-815F-6DF88BCF403EQ28594810-C8A646DB-D6E8-46E8-A369-05D4070FA9F8Q28603611-FCE5458A-B806-4185-A9D2-9F7090E0C8B3Q28647166-156224AE-6924-45ED-9A57-DC78913D37D9Q28757606-047B3325-1C7B-4A0B-A4B5-73FAE249C54DQ30532710-F8682C50-D418-49C3-8880-F56B722C226BQ33243274-B9662727-E197-4468-A1E2-12DF4C76D921
P2860
Protease-activated receptor 3 is a second thrombin receptor in humans
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Protease-activated receptor 3 is a second thrombin receptor in humans
@ast
Protease-activated receptor 3 is a second thrombin receptor in humans
@en
Protease-activated receptor 3 is a second thrombin receptor in humans
@en-gb
Protease-activated receptor 3 is a second thrombin receptor in humans
@nl
type
label
Protease-activated receptor 3 is a second thrombin receptor in humans
@ast
Protease-activated receptor 3 is a second thrombin receptor in humans
@en
Protease-activated receptor 3 is a second thrombin receptor in humans
@en-gb
Protease-activated receptor 3 is a second thrombin receptor in humans
@nl
prefLabel
Protease-activated receptor 3 is a second thrombin receptor in humans
@ast
Protease-activated receptor 3 is a second thrombin receptor in humans
@en
Protease-activated receptor 3 is a second thrombin receptor in humans
@en-gb
Protease-activated receptor 3 is a second thrombin receptor in humans
@nl
P2093
P3181
P356
P1433
P1476
Protease-activated receptor 3 is a second thrombin receptor in humans
@en
P2093
A J Connolly
H Ishihara
S R Coughlin
P2888
P3181
P356
10.1038/386502A0
P407
P577
1997-04-03T00:00:00Z
P5875
P6179
1007679336